[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

Christine Rousset-Jablonski 1 Frédéric Selle 2 Elodie Adda-Herzog François Planchamp Lise Selleret Christophe Pomel 3, 4 Nathalie Chabbert-Buffet 5 Emile Darai 5 Patricia Pautier 6 Florence Trémollières 7 Frédéric Guyon 8 Roman Rouzier 9 Valérie Laurence Nicolas Chopin 10, 1 Cécile Faure-Conter 1 Enrica Bentivegna 11 Marie-Cécile Vacher-Lavenu 12 Catherine Lhomme 11 Anne Floquet 13 Isabelle Treilleux 1, 14 Fabrice Lecuru 15 Sébastien Gouy 11 Elsa Kalbacher 6 Catherine Genestie 16 Thibault de La Motte Rouge 17 Gwenaël Ferron 18 Mojgan Devouassoux-Shisheboran 19 Jean-Emmanuel Kurtz 20 Moïse Namer 21 Florence Joly 22 Eric Pujade-Lauraine 23 Michael Grynberg 24 Denis Querleu 18 Philippe Morice 25 Anne Gompel 26, 12 Isabelle Ray-Coquard 27, 1
Abstract : Rare ovarian tumors include complex borderline ovarian tumors, sex-cord tumors, germ cell tumors, and rare epithelial tumors. Indications and modalities of fertility preservation, infertility management and contraindications for hormonal contraception or menopause hormone therapy are frequent issues in clinical practice. A panel of experts from the French national network dedicated to rare gynaecological cancers, and of experts in reproductive medicine and gynaecology have worked on guidelines about fertility preservation, contraception and menopause hormone therapy in women treated for ovarian rare tumors.
Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01926591
Contributor : Mouniati Colo <>
Submitted on : Monday, November 19, 2018 - 12:52:40 PM
Last modification on : Saturday, May 4, 2019 - 1:45:33 AM

Identifiers

Citation

Christine Rousset-Jablonski, Frédéric Selle, Elodie Adda-Herzog, François Planchamp, Lise Selleret, et al.. [Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].. Bulletin du Cancer, John Libbey Eurotext, 2018, 105 (3), pp.299 - 314. ⟨10.1016/j.bulcan.2017.10.032⟩. ⟨hal-01926591⟩

Share

Metrics

Record views

68